0001628280-22-004518.txt : 20220301
0001628280-22-004518.hdr.sgml : 20220301
20220301161625
ACCESSION NUMBER: 0001628280-22-004518
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220301
DATE AS OF CHANGE: 20220301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DiBiase Mary
CENTRAL INDEX KEY: 0001880179
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38295
FILM NUMBER: 22698225
MAIL ADDRESS:
STREET 1: 61 NORTH BEACON STREET, 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: X4 Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0001501697
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273181608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
BUSINESS PHONE: 857-529-8300
MAIL ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
FORMER COMPANY:
FORMER CONFORMED NAME: Arsanis, Inc.
DATE OF NAME CHANGE: 20100920
4
1
wf-form4_164616936069234.xml
FORM 4
X0306
4
2022-03-01
0
0001501697
X4 Pharmaceuticals, Inc
XFOR
0001880179
DiBiase Mary
C/O X4 PHARMACEUTICALS INC.
61 NORTH BEACON STREET 4TH FLOOR
BOSTON
MA
02134
0
1
0
0
Chief Operating Officer
Common Stock
2022-03-01
4
A
0
105000
0
A
182899
D
Grant of restricted stock units to the Reporting Person under the Issuer's Amended and Restated 2017 Equity Incentive Plan with each restricted stock unit representing the right to receive one share of common stock on the applicable vesting date. No amount was paid upon the grant of the restricted stock units. The restricted stock units vest in two equal annual installments on March 1, 2023 and March 1, 2024, subject to the Reporting Person continuing to provide service as an employee of the Issuer through such date.
Of the shares of common stock reported, 177,748 shares represent unvested restricted stock units.
/s/ Derek M. Meisner, attorney-in-fact
2022-03-01